In Our Study We Compare Results of Two Oncoplastic Breast Surgery (short Scar Reduction Mammoplasty and Wise Pattern Reduction Mammoplasty) As Surgical Treatment of Breast Cancer

March 22, 2025 updated by: Ahmed Gadelkarim Mohamed, Sohag University

Evaluation of Short Scar Periareolar Inferior Pedicle Reduction Mammoplasty in Oncoplastic Breast Surgery

in our study we compare results of two oncoplastic breast surgery (short scar reduction mammoplasty and wise pattern reduction mammoplasty) as surgical treatment of breast cancer

Study Overview

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Sohag, Egypt, 82524
        • Sohag University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

female patients aged from 25 years to 75 years with early breast cancer that meet inclusion and exclusion criteria

Description

Inclusion Criteria:

  1. Female patients with ages ranging from 25 to 75 years.
  2. Patients with operable breast cancer (Stage I, II and IIIa).
  3. Patients with moderate to large /ptotic breasts.

Exclusion Criteria:

  1. Patients with a contraindication to breast conservative surgery:

    1. Multi-centric disease that can't be incorporated by local excision through a single incision that achieves adequate safety margin and satisfactory cosmetic results.
    2. inflammatory carcinoma.
    3. Contraindications to postoperative radiation e.g. pregnancy, pre-existing lung disease with reduced diffusing capacity and pulmonary TB.
    4. diffuse suspicious malignant micro-calcification on mammography.
    5. inability to attain negative surgical margins.
    6. cardiomyopathy
    7. connective tissue disorders with significant vasculitis.
  2. Previous chest wall or breast radiation.
  3. Patients' refusal participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
short scar periareolar inferior pedicle reduction mammoplasty
oncoplastic reduction mammoplasty through peri-areolar incision
reduction mammoplasty that minimizes scar with better cosmetic outcomes
wise pattern reduction mammoplasty
reduction mammoplasty through inverted T incision

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oncological outcomes
Time Frame: 1 year
detect incidence of local recurrence of malignancy
1 year
post operative complications
Time Frame: 1 month
surgical complications
1 month
cosmetic outcomes
Time Frame: 1 year
patients' satisfaction with their breast
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2025

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

March 17, 2025

First Submitted That Met QC Criteria

March 22, 2025

First Posted (Actual)

March 28, 2025

Study Record Updates

Last Update Posted (Actual)

March 28, 2025

Last Update Submitted That Met QC Criteria

March 22, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • soh-med-25-3-2md

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on short scar periareolar inferior pedicle reduction mammoplasty

Subscribe